McKesson v. United States

3 Ct. Cust. 515, 1913 WL 19718, 1913 CCPA LEXIS 12
CourtCourt of Customs and Patent Appeals
DecidedFebruary 1, 1913
DocketNo. 967
StatusPublished
Cited by11 cases

This text of 3 Ct. Cust. 515 (McKesson v. United States) is published on Counsel Stack Legal Research, covering Court of Customs and Patent Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McKesson v. United States, 3 Ct. Cust. 515, 1913 WL 19718, 1913 CCPA LEXIS 12 (ccpa 1913).

Opinion

MontgomeRV, Presiding Judge,

delivered the opinion of the court.

The merchandise which is the subject of this appeal is menthol. It is also 'known as peppermint crystals and appears to be imported from Japan under that name. It is procured by distilling the peppermint plant and collecting the oil from the distillate. The oil is then chilled or frozen and the portion which crystallizes constitutes the menthol. It was assessed for duty as a medicinal preparation under [516]*516paragraph. 65 of the tariff act of 1909. It is claimed, by the importers to be classifiable in the alternative either at one-fourth of 1 cent per pound plus 10 per cent ad valorem under paragraph 20 as drugs advanced in value beyond the requirements for packing, or as free of duty under paragraph 559 as drugs in a crude state, or as a non-enumerated manufactured article. The chief reliance of the importer is that this menthol should be classified as a drug in a crude state, and it is said in the brief of counsel that it is the crudest form of menthol.

Paragraph 559 provides for—

Drugs, such as barks, beans, berries, balsams, buds, bulbs, bulbous roots, excrescences, fruits, flowers, dried fibers, dried insects, grains, gums, gum resin, herbs, leaves, lichens, mosses, nuts, nutgalls, roots, stems, spices, vegetables, seeds (aromatic, not garden seeds),-seeds of morbid growth, weeds, and woods used expressly for dyeing or tanning; any of the foregoing which are natural and uncompounded drugs and not edible and not specially provided for in this section, and are in a crude state, not advanced in value or condition by any process or treatment whatever beyond that essential to the proper packing of the drugs and the prevention of decay or deterioration pending manufacture: * * *.

This article is not provided for in the free fist by name. It is not found as a natural drug, but is the result of two processes, first, distillation, and, second, the cooling process by which the menthol is separated from the oil of peppermint. It is a manufacture from the peppermint plant.

Reliance is placed upon the case G. A. 6253 (T. D. 26995), affirmed in United States Circuit Court in T. D. 28576, and on the case of United States v. Sheldon (2 Ct. Cust. Appls., 485; T. D. 32245). In each of these cases it will be noticed that the article held to be a crude material was provided for eo nomine in the tariff act. In the one case camphor was provided for. In the other case gum resin. Camphor is itself a product of the camphor tree, and before any substance derived from the tree could be properly called camphor it must have been manufactured. So, in the case of gum resin, crude, "not advanced in value or condition by any process or treatment whatever beyond that essential tp the proper packing of the drugs,” it was held in the case of United States v. Sheldon that any process by which nothing other than gum resin was produced was not a process of manufacture which took it out of this paragraph. In other words, that the mere removal of impurities did not make the substance of gum resin which was left other than gum resin.

But in the present case there is no such substance as menthol provided for in terms in the tariff act. The herb or peppermint plant might properly be called a crude drug, but this article is not such.

[517]*517The case of the United States v. Merck et al. (66 Fed., 251), dealing with elaterium, is not controlling. The substance in that case was imported in little cakes and varied much in quality. It was not used in this form.by the physician. The manufacturer extracted from the cakes their vital principle, which was known as “elaterine.” It was held that the imported article was not a medicinal preparation, but an article from which a medicinal preparation could be made. It was said:

It is a deposit from the juice or is the evaporated juice of .the fruit, and from it its active principle is subsequently extracted.

So, in the case of Cowl v. United States (124 Fed., 475). The subject matter of the importation was a drug known as guaraña. It was prepared and imported in the form of a dark brown, hard, sausage-shaped roll a foot or more in length and from 2 to 3 inches in diameter, and consisting of a paste prepared from the seeds of Paullinia sorbilis, the process consisting in shelling the seeds and moistening them in water, removing a papery film over the kernel, pounding them in a mortar, sufficient water being added to reduce it to a semisolid consistency, the article then being made into the form of rolls and wrapped in leaves and dried in the sun or by the fire. The testimony was' that it was sold to manufacturers and wholesale dealers, but not to retail druggists, as it was never used as a medicine in the condition in which it was imported, but before being used was prepared as a powder, elixir, or extract, crushed leaves and other impurities having been removed in the process of preparation.

These cases are clearly distinguishable from the present. For, as we shall see in the present case, the article as imported is in fact used for medicinal purposes, without any chemical or other change in the product itself. It is said in the brief of counsel that this article is not used as imported. It is not generally used by itself in the form as imported, but that it is used without purification as an ingredient with carriers or in solution appears, as we think, by the overwhelming weight of the testimony and by the testimony of the importers' witnesses.

Mr. Gane, who was a witness produced on behalf of the protestants, was asked:

Is menthol for use medicinally always incorporated with other ingredients before it is used by the patient? — A. Yes; in its crude form I don’t think it is ever used directly; it has to be compounded with some other preparation before it is fit for use by the patient.
By General Appraiser McClelland. 'Well, is its condition changed when it is compounded other than being mixed with other ingredients?
A. Oh, no; simply brought into solution or mixed up in powdered form.
Q. It is used in its present form in combination with other articles? — A. Yes; for medicinal purposes.

[518]*518Further on this witness testified:

Q. It comes here in bulk? — A. Yes, sir.
Q. And what manipulation is it subjected to in your hands, as druggists, when you receive it? — A. Well, sometimes we purify this preparation before we use it for medicinal purposes, according to what we want to use it for.
Q. Refine it? — A. Yes, sir.
. Q. And you use it without refining it frequently, do you? — A. Yes, sir.
Q. And it goes into the market in the form in which it appears in this bottle? — A. Yes, sir.
Q. And do you know for what particular use it may be applied, or is applied, in the form that it appears in that bottle? — A. In the form it appears in that bottle I don’t think it is applied for any particular use. To my knowledge, it is not applied in that form at all.
Q. Does it go into the hands of the retail druggists in that form? — A. Yes, sir. * * *
Q.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Biddle Sawyer Corp. v. United States
48 Cust. Ct. 30 (U.S. Customs Court, 1962)
Sandoz Chemical Works, Inc. v. United States
47 Cust. Ct. 80 (U.S. Customs Court, 1961)
United States v. P. John Hanrahan, Inc.
45 C.C.P.A. 120 (Customs and Patent Appeals, 1958)
Roche-Organon, Inc. v. United States
35 C.C.P.A. 99 (Customs and Patent Appeals, 1948)
Roche-Organon, Inc. v. United States
12 Cust. Ct. 164 (U.S. Customs Court, 1944)
Synthetic Patents Co. v. United States
11 Cust. Ct. 98 (U.S. Customs Court, 1943)
Gresham v. United States
8 Cust. Ct. 122 (U.S. Customs Court, 1942)
United States v. Franklin
19 C.C.P.A. 65 (Customs and Patent Appeals, 1931)
Smith & Son Manufacturing Co. v. United States
15 Ct. Cust. 277 (Customs and Patent Appeals, 1927)
United States v. Hillier's Son Co.
14 Ct. Cust. 216 (Customs and Patent Appeals, 1926)

Cite This Page — Counsel Stack

Bluebook (online)
3 Ct. Cust. 515, 1913 WL 19718, 1913 CCPA LEXIS 12, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mckesson-v-united-states-ccpa-1913.